143 related articles for article (PubMed ID: 26761267)
21. Injectable contraception.
Haider S; Darney PD
Clin Obstet Gynecol; 2007 Dec; 50(4):898-906. PubMed ID: 17982332
[TBL] [Abstract][Full Text] [Related]
22. Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera).
Cromer BA
Curr Opin Obstet Gynecol; 1999 Oct; 11(5):467-71. PubMed ID: 10526923
[TBL] [Abstract][Full Text] [Related]
23. Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents.
Harel Z; Biro F; Kollar L; Riggs S; Flanagan P; Vaz R
J Pediatr Adolesc Gynecol; 2002 Jun; 15(3):153-8. PubMed ID: 12106752
[TBL] [Abstract][Full Text] [Related]
24. Two recent studies find Depo-Provera use increases HIV risk.
Harper KN
AIDS; 2015 Jun; 29(9):N1. PubMed ID: 25870992
[No Abstract] [Full Text] [Related]
25. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium.
Miller L; Patton DL; Meier A; Thwin SS; Hooton TM; Eschenbach DA
Obstet Gynecol; 2000 Sep; 96(3):431-9. PubMed ID: 10960638
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptoms and Depo-Provera.
Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
[TBL] [Abstract][Full Text] [Related]
27. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
[TBL] [Abstract][Full Text] [Related]
28. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
29. Depo-provera: contraceptive risk?
Rosenfield A
Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
[TBL] [Abstract][Full Text] [Related]
30. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
31. [Contraception with Depo-Provera. Report of a series of 930 women].
Mahjoub S; Lebbi I; Dakhli R; Smaïli L; Ben Hmjd R; Ben Romdhane M; Zouari F; Hamzaoui R
Tunis Med; 2000 Nov; 78(11):662-6. PubMed ID: 11155390
[TBL] [Abstract][Full Text] [Related]
32. [Contraception with depot gestagens].
Koryntová D; Cepický P; Zivný J
Ceska Gynekol; 2001 May; 66(3):202-8. PubMed ID: 11464383
[TBL] [Abstract][Full Text] [Related]
33. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
Mauck CK; Callahan MM; Baker J; Arbogast K; Veazey R; Stock R; Pan Z; Morrison CS; Chen-Mok M; Archer DF; Gabelnick HL
Contraception; 1999 Jul; 60(1):15-24. PubMed ID: 10549448
[TBL] [Abstract][Full Text] [Related]
34. Depo Provera: a profile of current users.
Jarman H; Kovacs GT; Westcott M
Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
[TBL] [Abstract][Full Text] [Related]
35. Medroxyprogesterone acetate [Depo Provera] injections. Development of striae.
Gupta M
Br J Fam Plann; 2000 Apr; 26(2):104-5. PubMed ID: 10773604
[TBL] [Abstract][Full Text] [Related]
36. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
37. A case for concern?
Gartland A
Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
[TBL] [Abstract][Full Text] [Related]
38. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
39. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
40. Vaginal atrophy and genital pain in women on depot medroxyprogesterone acetate contraceptive injection.
Perkins N
Aust N Z J Obstet Gynaecol; 2024 Apr; 64(2):160-164. PubMed ID: 37817446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
